TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs11756275
log Bayes Factor = 55.962
Chromosome 6   position 27,007,113  (GRCh37) Explore rs11756275 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E83.1 Disorders of iron metabolism
0.000 0.000 1.000
K90.0 Coeliac disease
1.000 0.000 0.000
E10.9 Without complications
0.972 0.028 0.000
E10 Insulin-dependent diabetes mellitus
0.959 0.041 0.000
K90 Intestinal malabsorption
0.948 0.052 0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.920 0.080 0.000
K90.9 Intestinal malabsorption, unspecified
0.870 0.130 0.000
E10.6 With other specified complications
0.836 0.164 0.000
E10-E14 Diabetes mellitus
0.810 0.190 0.000
R31 Unspecified haematuria
0.000 0.203 0.797
E10.3 With ophthalmic complications
0.795 0.205 0.000
E10.2 With renal complications
0.791 0.209 0.000
E10.7 With multiple complications
0.772 0.228 0.000
E10.4 With neurological complications
0.755 0.245 0.000
E10.8 With unspecified complications
0.728 0.272 0.000
E10.1 With ketoacidosis
0.726 0.274 0.000
E16.2 Hypoglycaemia, unspecified
0.725 0.275 0.000
E16 Other disorders of pancreatic internal secretion
0.715 0.285 0.000
E14 Unspecified diabetes mellitus
0.712 0.288 0.000
E10.5 With peripheral circulatory complications
0.712 0.288 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.710 0.290 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.707 0.293 0.000
K90.3 Pancreatic steatorrhoea
0.680 0.320 0.000
K90.2 Blind loop syndrome, not elsewhere classified
0.680 0.320 0.000
K90.1 Tropical sprue
0.680 0.320 0.000
E10.0 With coma
0.667 0.333 0.000
E20-E35 Disorders of other endocrine glands
0.648 0.352 0.000
E13 Other specified diabetes mellitus
0.632 0.368 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.598 0.402 0.000
K90.8 Other intestinal malabsorption
0.592 0.408 0.000
E14.5 With peripheral circulatory complications
0.582 0.418 0.000
E12 Malnutrition-related diabetes mellitus
0.581 0.419 0.000
E14.1 With ketoacidosis
0.574 0.426 0.000
E14.6 With other specified complications
0.571 0.429 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.556 0.444 0.000
E21.0 Primary hyperparathyroidism
0.556 0.444 0.000
E14.3 With ophthalmic complications
0.548 0.451 0.000
E14.2 Withrenal complications
0.548 0.452 0.000
E14.8 With unspecified complications
0.539 0.461 0.000
E13.9 Without complications
0.532 0.468 0.000
E14.4 With neurological complications
0.513 0.487 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.513 0.487 0.000
E16.8 Other specified disorders of pancreatic internal secretion
0.513 0.487 0.000
E16.4 Abnormal secretion of gastrin
0.513 0.487 0.000
E16.3 Increased secretion of glucagon
0.513 0.487 0.000
E14.7 With multiple complications
0.511 0.489 0.000
E14.0 With coma
0.511 0.489 0.000
E23 Hypofunction and other disorders of pituitary gland
0.509 0.491 0.000
E15 Nondiabetic hypoglycaemic coma
0.509 0.491 0.000
E40-E46 Malnutrition
0.507 0.493 0.000
E28 Ovarian dysfunction
0.504 0.496 0.000
E21.3 Hyperparathyroidism, unspecified
0.501 0.499 0.000
E25 Adrenogenital disorders
0.499 0.501 0.000
E31 Polyglandular dysfunction
0.495 0.505 0.000
E22 Hyperfunction of pituitary gland
0.475 0.525 0.000
E34 Other endocrine disorders
0.468 0.532 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.465 0.535 0.000
E32 Diseases of thymus
0.465 0.535 0.000
E30 Disorders of puberty, not elsewhere classified
0.465 0.535 0.000
E27 Other disorders of adrenal gland
0.465 0.535 0.000
E21.4 Other specified disorders of parathyroid gland
0.463 0.537 0.000
E24 Cushing's syndrome
0.462 0.538 0.000
E26 Hyperaldosteronism
0.460 0.540 0.000
E13.8 With unspecified complications
0.453 0.547 0.000
E13.7 With multiple complications
0.453 0.547 0.000
E13.6 With other specified complications
0.453 0.547 0.000
E13.5 With peripheral circulatory complications
0.453 0.547 0.000
E13.4 With neurological complications
0.453 0.547 0.000
E13.2 With renal complications
0.453 0.547 0.000
E13.1 With ketoacidosis
0.453 0.547 0.000
E13.0 With coma
0.453 0.547 0.000
E23.2 Diabetes insipidus
0.444 0.556 0.000
E16.1 Other hypoglycaemia
0.443 0.557 0.000
E50-E64 Other nutritional deficiencies
0.427 0.573 0.000
E28.2 Polycystic ovarian syndrome
0.425 0.575 0.000
E23.6 Other disorders of pituitary gland
0.423 0.577 0.000
E12.9 Without complications
0.416 0.583 0.000
E12.8 With unspecified complications
0.416 0.583 0.000
E12.7 With multiple complications
0.416 0.583 0.000
E12.6 With other specified complications
0.416 0.583 0.000
E12.5 With peripheral circulatory complications
0.416 0.583 0.000
E12.4 With neurological complications
0.416 0.583 0.000
E12.3 With ophthalmic complications
0.416 0.583 0.000
E12.2 With renal complications
0.416 0.583 0.000
E12.1 With ketoacidosis
0.416 0.583 0.000
E12.0 With coma
0.416 0.583 0.000
E27.1 Primary adrenocortical insufficiency
0.416 0.584 0.000
E20 Hypoparathyroidism
0.416 0.584 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.409 0.591 0.000
E22.1 Hyperprolactinaemia
0.409 0.591 0.000
E13.3 With ophthalmic complications
0.404 0.596 0.000
N40 Hyperplasia of prostate
0.000 0.600 0.400
E21.2 Other hyperparathyroidism
0.400 0.600 0.000
E24.2 Drug-induced Cushing's syndrome
0.395 0.605 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.392 0.608 0.000
E34.8 Other specified endocrine disorders
0.391 0.609 0.000
E31.0 Autoimmune polyglandular failure
0.386 0.614 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.369 0.631 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.365 0.635 0.000
E23.1 Drug-induced hypopituitarism
0.365 0.635 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.363 0.636 0.000
E45 Retarded development following protein-energy malnutrition
0.363 0.636 0.000
E43 Unspecified severe protein-energy malnutrition
0.363 0.636 0.000
E42 Marasmic kwashiorkor
0.363 0.636 0.000
E41 Nutritional marasmus
0.363 0.636 0.000
E40 Kwashiorkor
0.363 0.636 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.363 0.637 0.000
E46 Unspecified protein-energy malnutrition
0.363 0.637 0.000
E28.9 Ovarian dysfunction, unspecified
0.362 0.638 0.000
E28.8 Other ovarian dysfunction
0.362 0.638 0.000
E28.1 Androgen excess
0.362 0.638 0.000
E28.0 Oestrogen excess
0.362 0.638 0.000
E25.9 Adrenogenital disorder, unspecified
0.358 0.642 0.000
E25.8 Other adrenogenital disorders
0.358 0.642 0.000
E26.0 Primary hyperaldosteronism
0.356 0.644 0.000
E31.9 Polyglandular dysfunction, unspecified
0.355 0.645 0.000
E31.8 Other polyglandular dysfunction
0.355 0.645 0.000
E31.1 Polyglandular hyperfunction
0.355 0.645 0.000
E24.8 Other Cushing's syndrome
0.343 0.656 0.000
E22.0 Acromegaly and pituitary gigantism
0.342 0.658 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.340 0.660 0.000
E22.8 Other hyperfunction of pituitary gland
0.340 0.660 0.000
E27.3 Drug-induced adrenocortical insufficiency
0.338 0.661 0.000
E34.5 Androgen resistance syndrome
0.336 0.664 0.000
E34.4 Constitutional tall stature
0.336 0.664 0.000
E34.3 Short stature, not elsewhere classified
0.336 0.664 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.336 0.664 0.000
E34.1 Other hypersecretion of intestinal hormones
0.336 0.664 0.000
E29 Testicular dysfunction
0.334 0.666 0.001
E30.9 Disorder of puberty, unspecified
0.333 0.667 0.000
E30.8 Other disorders of puberty
0.333 0.667 0.000
E30.1 Precocious puberty
0.333 0.667 0.000
E30.0 Delayed puberty
0.333 0.667 0.000
E32.9 Disease of thymus, unspecified
0.333 0.667 0.000
E32.8 Other diseases of thymus
0.333 0.667 0.000
E32.1 Abscess of thymus
0.333 0.667 0.000
E32.0 Persistent hyperplasia of thymus
0.333 0.667 0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.333 0.667 0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.333 0.667 0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.333 0.667 0.000
E27.5 Adrenomedullary hyperfunction
0.333 0.667 0.000
E27.0 Other adrenocortical overactivity
0.333 0.667 0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.332 0.668 0.000
E24.3 Ectopic ACTH syndrome
0.332 0.668 0.000
E24.1 Nelson's syndrome
0.332 0.668 0.000
E26.8 Other hyperaldosteronism
0.330 0.670 0.000
E26.1 Secondary hyperaldosteronism
0.330 0.670 0.000
E61 Deficiency of other nutrient elements
0.326 0.674 0.000
E56 Other vitamin deficiencies
0.320 0.680 0.000
E28.3 Primary ovarian failure
0.318 0.682 0.000
E34.0 Carcinoid syndrome
0.317 0.682 0.000
E14.9 Without complications
0.315 0.685 0.000
E24.0 Pituitary-dependent Cushing's disease
0.308 0.692 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.306 0.694 0.000
E63 Other nutritional deficiencies
0.306 0.694 0.000
E50 Vitamin A deficiency
0.306 0.694 0.000
E60 Dietary zinc deficiency
0.306 0.694 0.000
E59 Dietary selenium deficiency
0.306 0.694 0.000
E54 Ascorbic acid deficiency
0.306 0.694 0.000
E52 Niacin deficiency [pellagra]
0.306 0.694 0.000
E51 Thiamine deficiency
0.304 0.696 0.000
E20.8 Other hypoparathyroidism
0.298 0.702 0.000
E20.1 Pseudohypoparathyroidism
0.298 0.702 0.000
E20.0 Idiopathic hypoparathyroidism
0.298 0.702 0.000
E55 Vitamin D deficiency
0.298 0.702 0.000
E27.2 Addisonian crisis
0.295 0.705 0.000
E26.9 Hyperaldosteronism, unspecified
0.291 0.709 0.000
E58 Dietary calcium deficiency
0.289 0.711 0.000
E23.7 Disorder of pituitary gland, unspecified
0.280 0.719 0.000
E23.0 Hypopituitarism
0.279 0.721 0.000
E27.9 Disorder of adrenal gland, unspecified
0.273 0.727 0.000
E34.9 Endocrine disorder, unspecified
0.273 0.727 0.000
E61.1 Iron deficiency
0.268 0.732 0.000
E44.1 Mild protein-energy malnutrition
0.261 0.739 0.000
E44.0 Moderate protein-energy malnutrition
0.261 0.739 0.000
E29.9 Testicular dysfunction, unspecified
0.256 0.744 0.001
E20.9 Hypoparathyroidism, unspecified
0.249 0.751 0.000
E56.1 Deficiency of vitamin K
0.243 0.757 0.000
E29.8 Other testicular dysfunction
0.239 0.760 0.001
E29.0 Testicular hyperfunction
0.239 0.760 0.001
E61.9 Deficiency of nutrient element, unspecified
0.234 0.766 0.000
E61.8 Deficiency of other specified nutrient elements
0.234 0.766 0.000
E61.7 Deficiency of multiple nutrient elements
0.234 0.766 0.000
E61.6 Vanadium deficiency
0.234 0.766 0.000
E61.5 Molybdenum deficiency
0.234 0.766 0.000
E61.4 Chromium deficiency
0.234 0.766 0.000
E61.3 Manganese deficiency
0.234 0.766 0.000
E61.0 Copper deficiency
0.234 0.766 0.000
E56.9 Vitamin deficiency, unspecified
0.229 0.771 0.000
E56.8 Deficiency of other vitamins
0.229 0.771 0.000
E56.0 Deficiency of vitamin E
0.229 0.771 0.000
E65-E68 Obesity and other hyperalimentation
0.221 0.778 0.000
E24.9 Cushing's syndrome, unspecified
0.221 0.779 0.000
E50.9 Vitamin A deficiency, unspecified
0.220 0.780 0.000
E50.8 Other manifestations of vitamin A deficiency
0.220 0.780 0.000
E50.7 Other ocular manifestations of vitamin A deficiency
0.220 0.780 0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.220 0.780 0.000
E50.5 Vitamin A deficiency with night blindness
0.220 0.780 0.000
E50.4 Vitamin A deficiency with keratomalacia
0.220 0.780 0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.220 0.780 0.000
E50.2 Vitamin A deficiency with corneal xerosis
0.220 0.780 0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.220 0.780 0.000
E50.0 Vitamin A deficiency with conjunctival xerosis
0.220 0.780 0.000
E63.9 Nutritional deficiency, unspecified
0.220 0.780 0.000
E63.8 Other specified nutritional deficiencies
0.220 0.780 0.000
E63.1 Imbalance of constituents of food intake
0.220 0.780 0.000
E63.0 Essential fatty acid [EFA] deficiency
0.220 0.780 0.000
E64.9 Sequelae of unspecified nutritional deficiency
0.220 0.780 0.000
E64.8 Sequelae of other nutritional deficiencies
0.220 0.780 0.000
E64.3 Sequelae of rickets
0.220 0.780 0.000
E64.2 Sequelae of vitamin C deficiency
0.220 0.780 0.000
E64.1 Sequelae of vitamin A deficiency
0.220 0.780 0.000
E64.0 Sequelae of protein-energy malnutrition
0.220 0.780 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.218 0.781 0.000
E51.9 Thiamine deficiency, unspecified
0.218 0.782 0.000
E51.8 Other manifestations of thiamine deficiency
0.218 0.782 0.000
E51.1 Beriberi
0.218 0.782 0.000
I83.9 Varicose veins of lower extremities without ulcer or inflammation
0.000 0.783 0.217
E51.2 Wernicke's encephalopathy
0.216 0.784 0.000
E55.0 Rickets, active
0.213 0.786 0.000
E61.2 Magnesium deficiency
0.212 0.788 0.000
E53 Deficiency of other B group vitamins
0.209 0.791 0.000
N40-N51 Diseases of male genital organs
0.000 0.792 0.208
E55.9 Vitamin D deficiency, unspecified
0.205 0.795 0.000
E27.8 Other specified disorders of adrenal gland
0.193 0.806 0.000
N45 Orchitis and epididymitis
0.000 0.808 0.192
N41 Inflammatory diseases of prostate
0.000 0.814 0.186
N42 Other disorders of prostate
0.000 0.817 0.183
N42.1 Congestion and haemorrhage of prostate
0.000 0.820 0.180
N41.0 Acute prostatitis
0.000 0.821 0.179
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess
0.000 0.822 0.178
N49 Inflammatory disorders of male genital organs, not elsewhere classified
0.000 0.829 0.171
N46 Male infertility
0.000 0.830 0.170
E00-E07 Disorders of thyroid gland
0.166 0.834 0.000
E67 Other hyperalimentation
0.159 0.841 0.000
E68 Sequelae of hyperalimentation
0.159 0.841 0.000
N41.1 Chronic prostatitis
0.000 0.844 0.156
N51 Disorders of male genital organs in diseases classified elsewhere
0.000 0.849 0.151
E53.1 Pyridoxine deficiency
0.150 0.850 0.000
E53.0 Riboflavin deficiency
0.150 0.850 0.000
T39.1 4-Aminophenol derivatives
0.000 0.851 0.149
N42.8 Other specified disorders of prostate
0.000 0.853 0.147
E83 Disorders of mineral metabolism
0.012 0.853 0.134
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess
0.000 0.854 0.146
E53.9 Vitamin B deficiency, unspecified
0.140 0.860 0.000
N44 Torsion of testis
0.000 0.861 0.139
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.862 0.138
N41.3 Prostatocystitis
0.000 0.866 0.133
N49.8 Inflammatory disorders of other specified male genital organs
0.000 0.866 0.133
N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens
0.000 0.867 0.133
N42.3 Dysplasia of prostate
0.000 0.869 0.131
N49.2 Inflammatory disorders of scrotum
0.000 0.871 0.129
E06 Thyroiditis
0.129 0.871 0.000
N42.0 Calculus of prostate
0.000 0.873 0.127
N49.9 Inflammatory disorder of unspecified male genital organ
0.000 0.877 0.123
N49.0 Inflammatory disorders of seminal vesicle
0.000 0.877 0.123
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.880 0.120
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.880 0.120
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.119 0.881 0.000
E00 Congenital iodine-deficiency syndrome
0.119 0.881 0.000
N41.2 Abscess of prostate
0.000 0.881 0.119
E83.3 Disorders of phosphorus metabolism
0.003 0.882 0.115
E67.8 Other specified hyperalimentation
0.114 0.886 0.000
E67.3 Hypervitaminosis D
0.114 0.886 0.000
E67.2 Megavitamin-B6 syndrome
0.114 0.886 0.000
E67.1 Hypercarotenaemia
0.114 0.886 0.000
E67.0 Hypervitaminosis A
0.114 0.886 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.887 0.113
N50 Other disorders of male genital organs
0.000 0.889 0.111
N51.2 Balanitis in diseases classified elsewhere
0.000 0.889 0.111
N51.8 Other disorders of male genital organs in diseases classified elsewhere
0.000 0.891 0.108
N51.1 Disorders of testis and epididymis in diseases classified elsewhere
0.000 0.891 0.108
N51.0 Disorders of prostate in diseases classified elsewhere
0.000 0.891 0.108
N50.9 Disorder of male genital organs, unspecified
0.000 0.893 0.107
N41.8 Other inflammatory diseases of prostate
0.000 0.894 0.106
E02 Subclinical iodine-deficiency hypothyroidism
0.105 0.894 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.009 0.895 0.097
E83.8 Other disorders of mineral metabolism
0.009 0.895 0.097
E83.2 Disorders of zinc metabolism
0.009 0.895 0.097
E83.0 Disorders of copper metabolism
0.009 0.895 0.097
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.896 0.104
E06.3 Autoimmune thyroiditis
0.104 0.896 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.896 0.104
E07 Other disorders of thyroid
0.102 0.898 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.899 0.101
T39.4 Antirheumatics, not elsewhere classified
0.000 0.901 0.099
T39.2 Pyrazolone derivatives
0.000 0.901 0.099
N41.9 Inflammatory disease of prostate, unspecified
0.000 0.903 0.097
E06.9 Thyroiditis, unspecified
0.095 0.905 0.000
E06.4 Drug-induced thyroiditis
0.092 0.907 0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.092 0.907 0.000
E06.1 Subacute thyroiditis
0.092 0.907 0.000
E06.0 Acute thyroiditis
0.092 0.907 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.908 0.092
E11 Non-insulin-dependent diabetes mellitus
0.091 0.909 0.000
E65 Localised adiposity
0.089 0.911 0.000
T50.8 Diagnostic agents
0.000 0.912 0.088
E04 Other non-toxic goitre
0.087 0.913 0.000
E06.5 Other chronic thyroiditis
0.086 0.913 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.914 0.086
T40.2 Other opioids
0.000 0.914 0.086
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.086 0.914 0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.086 0.914 0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.086 0.914 0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.086 0.914 0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.086 0.914 0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.086 0.914 0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.086 0.914 0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.086 0.914 0.000
N42.2 Atrophy of prostate
0.000 0.916 0.084
N43 Hydrocele and spermatocele
0.000 0.917 0.083
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.917 0.083
E04.9 Non-toxic goitre, unspecified
0.082 0.918 0.000
E03 Other hypothyroidism
0.082 0.918 0.000
E53.8 Deficiency of other specified B group vitamins
0.077 0.923 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.923 0.077
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.923 0.077
E05 Thyrotoxicosis [hyperthyroidism]
0.076 0.924 0.000
T50.4 Drugs affecting uric acid metabolism
0.000 0.925 0.075
T50.7 Analeptics and opioid receptor antagonists
0.000 0.925 0.075
T50.5 Appetite depressants
0.000 0.925 0.075
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.925 0.075
T50.0 Mineralocorticoids and their antagonists
0.000 0.925 0.075
T39.0 Salicylates
0.000 0.925 0.075
E07.1 Dyshormogenetic goitre
0.073 0.927 0.000
E07.0 Hypersecretion of calcitonin
0.073 0.927 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.927 0.073
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.927 0.073
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.927 0.073
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.928 0.072
N50.0 Atrophy of testis
0.000 0.929 0.071
T50.1 Loop [high-ceiling] diuretics
0.000 0.929 0.071
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.930 0.070
E11.5 With peripheral circulatory complications
0.069 0.931 0.000
T40.5 Cocaine
0.000 0.932 0.068
E07.8 Other specified disorders of thyroid
0.067 0.933 0.000
E11.1 With ketoacidosis
0.067 0.933 0.000
E11.6 With other specified complications
0.066 0.934 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.934 0.066
T40.8 Lysergide [LSD]
0.000 0.934 0.066
T40.7 Cannabis (derivatives)
0.000 0.934 0.066
T40.3 Methadone
0.000 0.934 0.066
T40.1 Heroin
0.000 0.934 0.066
T40.0 Opium
0.000 0.934 0.066
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.934 0.066
T36 Poisoning by systemic antibiotics
0.000 0.934 0.066
E11.7 With multiple complications
0.065 0.935 0.000
N43.2 Other hydrocele
0.000 0.935 0.065
T40.4 Other synthetic narcotics
0.000 0.935 0.064
E07.9 Disorder of thyroid, unspecified
0.064 0.936 0.000
E04.8 Other specified non-toxic goitre
0.063 0.937 0.000
T42.1 Iminostilbenes
0.000 0.938 0.062
K90-K93 Other diseases of the digestive system
0.062 0.938 0.000
E29.1 Testicular hypofunction
0.060 0.938 0.002
T40.6 Other and unspecified narcotics
0.000 0.938 0.061
E11.8 With unspecified complications
0.060 0.940 0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.060 0.940 0.000
N43.0 Encysted hydrocele
0.000 0.940 0.060
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.941 0.059
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.941 0.059
T42.2 Succinimides and oxazolidinediones
0.000 0.941 0.059
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.941 0.059
E11.0 With coma
0.059 0.941 0.000
T42.0 Hydantoin derivatives
0.000 0.941 0.059
E03.5 Myxoedema coma
0.059 0.941 0.000
E03.4 Atrophy of thyroid (acquired)
0.059 0.941 0.000
E03.3 Postinfectious hypothyroidism
0.059 0.941 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.943 0.057
E66 Obesity
0.057 0.943 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.056 0.943 0.000
E11.2 With renal complications
0.056 0.944 0.000
E03.8 Other specified hypothyroidism
0.056 0.944 0.000
T47.4 Other laxatives
0.000 0.944 0.055
E05.0 Thyrotoxicosis with diffuse goitre
0.055 0.945 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.945 0.055
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.945 0.055
T47.7 Emetics
0.000 0.945 0.055
T47.6 Antidiarrhoeal drugs
0.000 0.945 0.055
T47.5 Digestants
0.000 0.945 0.055
T47.3 Saline and osmotic laxatives
0.000 0.945 0.055
T47.2 Stimulant laxatives
0.000 0.945 0.055
N43.4 Spermatocele
0.000 0.945 0.055
T47.0 Histamine H(2)-receptor antagonists
0.000 0.945 0.055
E05.5 Thyroid crisis or storm
0.054 0.945 0.000
E05.4 Thyrotoxicosis factitia
0.054 0.945 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.054 0.945 0.000
N43.1 Infected hydrocele
0.000 0.946 0.054
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.947 0.053
T41.5 Therapeutic gases
0.000 0.948 0.052
T41.4 Anaesthetic, unspecified
0.000 0.948 0.052
T41.3 Local anaesthetics
0.000 0.948 0.052
T41.2 Other and unspecified general anaesthetics
0.000 0.948 0.052
T41.1 Intravenous anaesthetics
0.000 0.948 0.052
T41.0 Inhaled anaesthetics
0.000 0.948 0.052
T49.9 Topical agent, unspecified
0.000 0.948 0.052
T49.8 Other topical agents
0.000 0.948 0.052
T49.7 Dental drugs, topically applied
0.000 0.948 0.052
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.948 0.052
T49.5 Ophthalmological drugs and preparations
0.000 0.948 0.052
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.948 0.052
T49.3 Emollients, demulcents and protectants
0.000 0.948 0.052
T49.2 Local astringents and local detergents
0.000 0.948 0.052
T49.1 Antipruritics
0.000 0.948 0.052
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.948 0.052
E03.9 Hypothyroidism, unspecified
0.052 0.948 0.000
E03.0 Congenital hypothyroidism with diffuse goitre
0.052 0.948 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.948 0.052
T37.5 Antiviral drugs
0.000 0.948 0.052
T37.4 Anthelminthics
0.000 0.948 0.052
T37.3 Other antiprotozoal drugs
0.000 0.948 0.052
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.948 0.052
T37.1 Antimycobacterial drugs
0.000 0.948 0.052
T37.0 Sulphonamides
0.000 0.948 0.052
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.948 0.051
T36.3 Macrolides
0.000 0.949 0.051
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.949 0.051
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.051 0.949 0.000
T42.3 Barbiturates
0.000 0.950 0.050
N47 Redundant prepuce, phimosis and paraphimosis
0.000 0.951 0.049
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.951 0.049
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.952 0.047
T48.4 Expectorants
0.000 0.952 0.047
T48.3 Antitussives
0.000 0.952 0.047
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.952 0.047
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.952 0.047
T48.0 Oxytocic drugs
0.000 0.952 0.047
E03.1 Congenital hypothyroidism without goitre
0.047 0.952 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.953 0.047
T36.8 Other systemic antibiotics
0.000 0.953 0.047
T36.7 Antifungal antibiotics, systemically used
0.000 0.953 0.047
T36.6 Rifamycins
0.000 0.953 0.047
T36.5 Aminoglycosides
0.000 0.953 0.047
T36.4 Tetracyclines
0.000 0.953 0.047
T36.2 Chloramphenicol group
0.000 0.953 0.047
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.953 0.047
D32.9 Meninges, unspecified
0.046 0.954 0.000
E66.0 Obesity due to excess calories
0.046 0.954 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.955 0.045
W20-W49 Exposure to inanimate mechanical forces
0.045 0.955 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.955 0.045
K93 Disorders of other digestive organs in diseases classified elsewhere
0.044 0.955 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.956 0.044
T48.5 Anti-common-cold drugs
0.000 0.956 0.044
W23 Caught, crushed, jammed or pinched in or between objects
0.043 0.957 0.000
W49 Exposure to other and unspecified inanimate mechanical forces
0.043 0.957 0.000
T38.9 Other and unspecified hormone antagonists
0.000 0.957 0.043
T38.7 Androgens and anabolic congeners
0.000 0.957 0.043
T38.5 Other oestrogens and progestogens
0.000 0.957 0.043
T38.4 Oral contraceptives
0.000 0.957 0.043
T38.2 Antithyroid drugs
0.000 0.957 0.043
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.958 0.042
E11.4 With neurological complications
0.041 0.959 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.959 0.041
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.959 0.041
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.959 0.041
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.959 0.041
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.959 0.041
T44.0 Anticholinesterase agents
0.000 0.959 0.041
W49.0 Home
0.041 0.959 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.959 0.041
W21 Striking against or struck by sports equipment
0.041 0.959 0.000
E66.1 Drug-induced obesity
0.041 0.959 0.000
T38.0 Glucocorticoids and synthetic analogues
0.000 0.959 0.040
E66.2 Extreme obesity with alveolar hypoventilation
0.040 0.960 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.960 0.039
E05.9 Thyrotoxicosis, unspecified
0.039 0.961 0.000
E11.3 With ophthalmic complications
0.039 0.961 0.000
E05.8 Other thyrotoxicosis
0.039 0.961 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.961 0.039
E83.4 Disorders of magnesium metabolism
0.007 0.961 0.031
N42.9 Disorder of prostate, unspecified
0.000 0.961 0.039
W29 Contact with other powered hand tools and household machinery
0.039 0.961 0.000
E04.0 Non-toxic diffuse goitre
0.038 0.962 0.000
W23.4 Street and highway
0.038 0.962 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.962 0.038
T38.1 Thyroid hormones and substitutes
0.000 0.963 0.037
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.963 0.037
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.963 0.037
T46.7 Peripheral vasodilators
0.000 0.963 0.037
W23.2 School, other institution and public administrative area
0.037 0.963 0.000
W45 Foreign body or object entering through skin
0.037 0.963 0.000
E04.1 Non-toxic single thyroid nodule
0.037 0.963 0.000
W34 Discharge from other and unspecified firearms
0.036 0.964 0.000
W44 Foreign body entering into or through eye or natural orifice
0.036 0.964 0.000
W49.8 Other specified place
0.036 0.964 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.965 0.035
T45.8 Other primarily systemic and haematological agents
0.000 0.965 0.035
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.965 0.035
T45.6 Fibrinolysis-affecting drugs
0.000 0.965 0.035
T45.4 Iron and its compounds
0.000 0.965 0.035
T45.3 Enzymes, not elsewhere classified
0.000 0.965 0.035
W29.9 Unspecified place
0.035 0.965 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.965 0.035
W31 Contact with other and unspecified machinery
0.035 0.965 0.000
T45.2 Vitamins, not elsewhere classified
0.000 0.965 0.035
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.965 0.035
T46.1 Calcium-channel blockers
0.000 0.965 0.035
W49.6 Industrial and construction area
0.035 0.965 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.965 0.034
W22 Striking against or struck by other objects
0.034 0.966 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.